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Abstract Mutations of eight to nine amino acids of IIIS5, IIIS6
and IVS6 segments were shown to reconstruct the dihydropyr-
idine (DHP) interaction site in the non-L-type K1E or K1A
calcium channels. The reconstructed site enabled enantiomer-
selective inhibition and activation of the expressed chimeras by
DHPs but failed to transfer voltage dependence of the current
inhibition. Here we show that transfer of four non-conserved
amino acids from the IS6 segment to the DHP-sensitive K1E
chimera increased the inhibition by (+)isradipine at the
hyperpolarized membrane potential of 3100 mV and enhanced
the voltage-dependent block.
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1. Introduction
The K1C subunit of the L-type calcium channel contains
high a⁄nity binding sites for organic channel blockers includ-
ing the dihydropyridines (DHPs), phenylalkylamines and ben-
zothiazepines (for review see [1]). Both native L-type calcium
channels and the expressed K1C subunit interact enantiomer-
selectively with DHPs [2]. The a⁄nity of the L-type calcium
channel for the DHP enantiomers increases with depolarized
membrane potential. This increase was attributed to the in-
creased availability of the channel in the inactivated state [3^
5].
The DHP sensitivity has been transferred successfully to the
DHP-insensitive K1E subunit [6] and K1A subunit [7,8]. Muta-
tion of two amino acid residues in IIIS5 (Y1295T, M1299Q),
three residues in IIIS6 (F1406I, F1409I, V1414M) and three
residues in IVS6 (I1706Y, F1707M, L1714I), yielding chimera
rEC10 [6], allowed a high a⁄nity interaction of the chimeric
channel with isradipine at a holding potential (HP) of
3100 mV. Sinnegger and coworkers [7] and Hockerman and
coworkers [8], who additionally mutated M1713I in the IVS6
segment, reported results which did not di¡er from those of
Ito and coworkers [6].
The reconstructed DHP site transferred enantiomer-selec-
tive activation and inhibition of the mutated channels by
DHPs, but still lacked the characteristic voltage dependence
of the inhibition. The cardiac and vascular splice variants of
the L-type calcium channel are blocked with a di¡erent a⁄n-
ity by several DHPs [9^12]. Analyses of the structural back-
grounds of this di¡erent sensitivity showed that the di¡erent
sensitivity depended on the splice variant of the IS6 segment
[13]. Therefore, we tested whether the transfer of amino acids
from the IS6 segment could further improve the reconstructed
DHP binding site. Here we report that transfer of four non-
conserved amino acids from the IS6 segment of the K1C sub-
unit to the DHP-sensitive chimera rEC10 of the K1E channel
further decreased the IC50 for isradipine at a HP of 3100 mV
and enhanced the voltage dependence of the block.
2. Materials and methods
2.1. Construction of chimeric channels and cell transfection
In the chimera rEC10 eight amino acid residues of the K1E sequence
were replaced by corresponding amino acids of the K1C sequence:
Y1295T and M1299Q in IIIS5; F1406I, F1409I and V1414M in
IIIS6; and I1706Y, F1707M and L1714I in IVS6. The construction
of chimera rEC10 has been described in [6]. For the construction of
rEC20, the KpnI (nt 658)-XhoI (nt 1271) fragment of the rEC10 sub-
unit [14] was subcloned in pUC18. Using a polymerase chain reaction
overlap extension technique, the following mutations were made in
the IS6 segment of the rEC10 sequence: N327P, L329I, I332V and
P333T. These mutations were con¢rmed by sequence analysis in the
subclone and in the full-length construct. The cDNAs for all chimeric
constructs were cloned into the pcDNA 3 vector (Invitrogen). HEK
293 cells were transfected with the K1Cÿb subunit [15] plasmids togeth-
er with the cDNA plasmids encoding the cardiac L2a and K2N-1 sub-
units by lipofection with LipofectAMINE (Gibco BRL, Life Technol-
ogies) at a DNA mass ratio of 1:1:1.
2.2. Electrophysiological recording and data analysis
The whole cell Ba2 currents were recorded using an EPC-9 ampli-
¢er (HEKA Elektronik GmbH, Lambrecht, Germany). The bath solu-
tion contained (in mM): NMDG, 125; BaCl2, 20; CsCl, 5; MgCl2, 1;
EGTA, 0.1; HEPES, 10; glucose, 10; pH 7.4 (HCl). The intracellular
solution contained (in mM): CsCl, 102; NaCl, 5; TEA-Cl, 10;
EGTA, 10; MgATP, 5; HEPES, 5; pH 7.4 (CsOH). All chemicals
were of the highest purity available. All experiments were carried out
with the + enantiomer of isradipine. The stock solutions of isradipine
was prepared in 96% ethanol, stored at 320‡C and diluted to the
required concentrations in the bath solution immediately before the
experiment. Isradipine was applied by a local solution changer and
reached the cell membrane within 1 s.
The capacity transient was compensated using the automatic pro-
cedure of the EPC-9 ampli¢er. Leak current was subtracted using the
P/4 procedure. Data were analyzed by the program package provided
by HEKA Elektronik and by Origin 4.0, Microcal Software Inc.,
Northampton, MA, USA. All values are means þ S.E.M.
3. Results and discussion
3.1. Voltage dependence of activation and inactivation of
chimeric channels
For reconstruction of the DHP binding site, we chose the
non-DHP-sensitive K1E channel. The mutation of eight amino
acids in the IIIS5, IIIS6 and IVS6 segments yielded the chi-
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meric rEC10 channel which has an isradipine IC50 value of
57.5 þ 2.7 nM at a HP of 3100 mV [6] (see also Fig. 2A). This
IC50 value is 5-fold higher than that determined for the wild
type K1C channel, which was 12.2 þ 0.9 nM at a HP of 380
mV. In agreement with the K1A chimeras [7,8], inhibition of
the rEC10 chimera lacked voltage dependence of the DHP
block. Obviously, DHP binding to the K1C subunit requires
additional, not yet identi¢ed amino acid(s). Analysis of the
di¡erent DHP sensitivity of the cardiac and smooth muscle
splice variants of L-type calcium channels pointed to a role of
the IS6 segment in the high a⁄nity interaction of the channels
with DHPs [13].
Fig. 1. A: I-V relations were measured by a sequence of 40 ms long pulses to the potentials between 350 mV and +80 mV applied each 5 s.
HP was 380 mV for the K1C channel (a) and 3100 mV for the K1E (7), rEC10 (F) and rEC20 (R) channels. Individual I-Vs were normalized
to the maximal inward current amplitude and then averaged. Solid lines are connectors of experimental points. B: Steady-state availability
curves were measured by applying the following protocol each 20 s: the membrane potential was shifted from HP for 5 s to the prepulse volt-
age, returned to the HP for 5 ms, switched for 40 ms to the test potential which was equivalent to the peak I-V relation of each individual cell
and returned to the HP. HP was 380 mV and prepulse voltages increased with a step +10 mV between 3100 mV and +40 mV for the K1C
channel (a). For the K1E (7), rEC10 (F) and rEC20 (R) channels, HP was 3100 mV and prepulse voltages varied between 3120 mV and
+20 mV. Solid lines are ¢ts of experimental data to the Boltzmann equation (see Table 1).
Fig. 2. A: Dose-response curves for inhibition of IBa by isradipine measured for the K1C channel (upper panel) from HPs of 380 mV (a,
n = 9), 350 mV (b, n = 9) and 330 mV (F, n = 8); for the K1E channel (middle panel) from HP of 380 mV (7, n = 11); for the rEC10 channel
(middle panel) from HP of 3100 mV (E, n = 7) and 370 mV (F, n = 8); for the rEC20 channel (lower panel) from a HP of 3100 mV (O,
n = 9) and 360 mV (R, n = 8). Solid lines are ¢ts of experimental data to the Hill equation (for resulting IC50s see Table 2). B: Representative
examples of current traces measured from K1C channel at HPs of 380 mV and 330 mV in the absence and presence of 30 nM and 0.3 nM is-
radipine, respectively. C: Representative examples of current traces measured from the rEC10 channel at HPs of 3100 mV and 370 mV in the
absence and presence of 3, 30 and 300 nM isradipine (in order of descending amplitude). D: Representative examples of current traces meas-
ured from the rEC20 channel at HPs of 3100 mV and 360 mV in the absence and presence of 1, 10 and 100 nM isradipine (in order of de-
scending amplitude).
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To test this hypothesis, we mutated N327P, L329I, I332V
and P333T of the IS6 segment of rEC10 chimera yielding
chimera rEC20 (see Section 2). First, we characterized the
voltage dependence of activation and inactivation of all used
channels (Fig. 1). In comparison to the K1C channel, the I-V
relation of the K1E channel was shifted by 310.8 mV (Table
1). The mutations of the rEC10 and rEC20 channels shifted
the I-V relations towards the curve of the K1C channel. In
comparison to the K1C channel, the quasi-steady-state inacti-
vation curve of the K1E channel was shifted by 350.1 mV
(Table 1) and virtually overlapped with the quasi-steady-state
inactivation curve of the rEC10 channel. The exchange of
amino acids in the IS6 segment moved the voltage dependence
of the inactivation of the rEC20 channels towards that of the
K1C channel.
3.2. Voltage dependence of current inhibition by isradipine
Inhibition of IBa by isradipine was tested by trains of 40 ms
long depolarizing pulses to the membrane potential corre-
sponding to the peak I-V relation of each individual cell.
Two to three minutes were allowed at each drug concentration
to establish new stable current amplitudes. The dose-response
relations were established for all four channels (Fig. 2A). The
DHP insensitivity of the K1E channel was con¢rmed at HP
380 mV (Fig. 2A, middle panel). The DHP-sensitive channels
were tested at hyperpolarized HP (380 mV for the K1C chan-
nel and 3100 mV for the rEC10 and rEC20 channels), at
which HPs the voltage-dependent inactivation of the channels
is virtually zero, and at a depolarized membrane potential
(330 mV for the K1C channel, 370 mV for the rEC10 and
360 mV for the rEC20 channels), at which HPs about 80% of
Fig. 3. Steady-state availability curves were measured as in Fig. 1 and ¢tted to the Boltzmann equation (solid lines in A^C). A: K1C channel,
HP of 380 mV, control conditions (E, n = 4) and the presence of 0.3 nM (b, n = 4), 3 nM (R, n = 4) and 30 nM (S, n = 4) isradipine. B:
rEC10 channel, HP of 3100 mV, control conditions (a, n = 8) and the presence of 3 nM (F, n = 5), 30 nM (b, n = 5) and 300 nM (R, n = 6) is-
radipine. C: rEC20 channel, HP of 3100 mV, control conditions (a, n = 7) and the presence of 3 nM (F, n = 9), 30 nM (b, n = 12) and 300
nM (R, n = 7) isradipine. D: Relation between shift of voltage for half-maximal channel inactivation (V0:5) and the inhibition of current ampli-
tude by the same isradipine concentration. The x coordinate of each experimental point represents amplitude inhibition at an HP of 380 mV
(K1C, a) or 3100 mV (rEC10, E or rEC20, O). Values are taken from experiments of Fig. 2A. The corresponding y coordinate represents shift
of V0:5 for steady-state availability by the same isradipine concentration. Values are taken from experiments in A^C.
Table 1
Voltage-dependent activation and inactivation of individual channel types
K1C K1E rEC10 rEC20
V0:5act (mV) 34.3 þ 0.2 315.1 þ 0.8 311.7 þ 0.6 39.1 þ 0.7
kact (mV) 4.9 þ 0.1 3.5 þ 0.5 4.7 þ 0.6 4.9 þ 0.7
n 11 11 8 8
V0:5inact (mV) 319.6 þ 0.3 369.7 þ 0.4 366.6 þ 0.1 358.6 þ 0.2
kinact (mV) 8.5 þ 0.2 8.4 þ 0.4 7.7 þ 0.1 9.1 þ 0.1
n 14 11 8 7
Values are the ¢ts of the ascending part of I-V relations from Fig. 1A and of the steady-state availability curves from Fig. 1B to the Boltz-
mann equation. V0:5act and V0:5inact represent voltages for half-maximal activation and inactivation, respectively; kact and kinact are correspond-
ing slope factors, n is number of cells tested.
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the channels are inactivated. This extent of the voltage-de-
pendent inactivation of the channels is greater than in qua-
si-steady-state inactivation curves showed in Fig. 1B because
of the presence of an additional slow voltage-dependent in-
activation which occurred in all channels. Apparently, com-
plete steady-state inactivation curves would require at least a
1 min long prepulse. Nevertheless, a negative shift in the volt-
age dependence of the inactivation of individual channels was
preserved. After a 5 s long prepulse, 80% of rEC10, rEC20
and K1C channels were inactivated at approximate membrane
potentials of 360 mV, 350 mV and 310 mV, respectively (see
Fig. 1B). When the HP was shifted to a more depolarized
value, 80% inactivation of rEC10, rEC20 and K1C channels
was reached at membrane potentials of about 370 mV, 360
mV and 330 mV, respectively. Therefore dose-response
curves in Fig. 2A show inhibition of rEC10, rEC20 and K1C
channels under the conditions when the numbers of inacti-
vated channels were approximately equal.
The di¡erences in the voltage dependence of the isradipine
interaction with individual channels is demonstrated also by
examples of current traces recorded in the absence and the
presence of isradipine. About the same extent of current in-
hibition was reached by 30 nM isradipine at an HP of 380
mV and by 0.3 nM isradipine at an HP of 330 mV in the wild
type K1C channel (Fig. 2B). Inhibition of the rEC10 channel
by isradipine was similar at both HPs, i.e. at 3100 mV and
370 mV (Fig. 2C). The shift of the HP from 3100 mV to 360
mV enhanced the ability of isradipine to inhibit the rEC20
channel (Fig. 2D). All dose-response curves were ¢tted to
the Hill equation. The voltage dependence of the IC50 values
is summarized in Table 2. A shift in the membrane potential
from 380 mV to 350 mV caused an 8-fold decrease in the
IC50 for the wild type K1C channel. A similar shift in the HP
from 3100 mV to 370 mV and 360 mV decreased the IC50
for the rEC10 channel only 1.9-fold and that for the rEC20
channel 5.4-fold. These values strongly support the hypothesis
that the mutations of chimera rEC20 not only enhanced isra-
dipine sensitivity of the channel at hyperpolarized membrane
potential, but also contributed to the voltage dependence of
the channel-drug interaction.
3.3. Shift of voltage dependence of channel availability by
isradipine
Voltage-dependent interaction between the channel and a
DHP is known to be accompanied by a shift in the voltage
dependence of channel availability [5]. Therefore, we com-
pared the ability of isradipine to shift the voltage dependence
of channel availability (Fig. 3). In the wild type K1C channel,
isradipine induced a typical potent concentration-dependent
shift of the availability curves towards more negative mem-
brane potentials (Fig. 3A). In contrast, only a small shift was
observed over a wide concentration range in the rEC10 chan-
nel (Fig. 3B). The ability of isradipine to shift the voltage
dependence of channel availability was improved by the mu-
tations of the rEC20 channel (Fig. 3C).
In the experiments shown in Fig. 3A^C, the isradipine con-
centrations used inhibited the current amplitude to di¡erent
extents. Fig. 3D compares the voltage shift induced by a spe-
ci¢c isradipine concentration with the extent of current inhib-
ition caused by the same drug concentration. As expected,
isradipine shifted the voltage of the inhibition curve strongly
with increasing current inhibition if the wild type K1C channel
was used. This relation was very shallow for the rEC10 chan-
nel, but was improved in the rEC20 channel. These data docu-
ment that the ability of isradipine to bind to and/or to stabi-
lize the inactivated state of the channels also depends on
amino acids of the IS6 segment.
In conclusion, we have demonstrated that amino acids of
the IS6 segment of the calcium channel directly participate in
forming the reconstructed DHP-interaction site in expressed
DHP-insensitive K1E and contribute to the voltage dependence
of the interaction. These ¢ndings con¢rm the photoa⁄nity
labeling data of Kalasz et al. [16] who reported that DHPs
interact with amino acids of the IS6 segment. However, our
results suggest also that high a⁄nity interaction between the
K1C channel and DHPs requires additional parts of the chan-
nel. These may involve additional amino acids of IS6, IIIS5,
IIIS6 and IVS6 segments, whose role in interaction with
DHPs has not been identi¢ed yet, and/or amino acids of other
transmembrane segments.
Acknowledgements: Supported by grants from the Deutsche For-
schungsgemeinschaft and the Fonds der Chemie.
References
[1] Hofmann, F., Lacinova¤, L. and Klugbauer, N. (1999) Rev. Phys-
iol. Biochem. Pharmacol. 139, 35^87.
[2] Triggle, D.J. (1991) J. Cardiovasc. Pharmacol. 18, (Suppl. 10)
S1^S6.
[3] Bean, B.P. (1984) Proc. Natl. Acad. Sci. USA 81, 6388^6392.
[4] Hess, P., Lansman, J.B. and Tsien, R.W. (1984) Nature 311, 538^
544.
[5] Sanguinetti, M.C. and Kass, R.S. (1984) Circ. Res. 55, 336^348.
[6] Ito, H., Klugbauer, N. and Hofmann, F. (1997) Mol. Pharmacol.
52, 735^740.
[7] Sinnegger, M.J., Wang, Z., Grabner, M., Hering, S., Striessnig,
J., Glossmann, H. and Mitterdorfer, J. (1997) J. Biol. Chem. 272,
27686^27693.
[8] Hockerman, G.H., Peterson, B.Z., Sharp, E., Tanada, T.N.,
Scheuer, T. and Catterall, W.A. (1997) Proc. Natl. Acad. Sci.
USA 94, 14906^14911.
[9] Welling, A., Kwan, Y.W., Bosse, E., Flockerzi, V., Hofmann, F.
and Kass, R.S. (1993) Circ. Res. 73, 974^980.
[10] Hu, H. and Marban, E. (1998) Mol. Pharmacol. 53, 902^907.
Table 2
Voltage dependence of IC50 (nM) for inhibition of wild type K1C and chimeric rEC10 and rEC20 channels by isradipine
HP (mV) 3100 380 370 360 350 330
K1C ^ 16 þ 2 ^ ^ 2.0 þ 0.3 0.25 þ 0.03
rEC10 64 þ 10 ^ 33 þ 7 ^ ^ ^
rEC20 27 þ 4 ^ ^ 5 þ 1 ^ ^
IC50 values for K1C, rEC10 and rEC20 channels are results of ¢ts of experimental data in Fig. 2A to the Hill equation. Holding potentials of
380 mV for K1C and 3100 mV for rEC10 and rEC20 channels represent membrane potentials at which virtually all channels were in a resting
state. At holding potentials of 330 mV (K1C), 370 mV (rEC10) and 360 mV (rEC20) about 80% of all channels were in an inactivated state.
FEBS 22033 18-5-99
L. Lacinova¤ et al./FEBS Letters 451 (1999) 152^156 155
[11] Zu«hlke, R.D., Bouron, A., Soldatov, N.M. and Reuter, H. (1998)
FEBS Lett. 427, 220^224.
[12] Morel, N., Buryi, V., Feron, O., Gomez, J.P., Christen, M.O.
and Godfraind, T. (1998) Br. J. Pharmacol. 125, 1005^1012.
[13] Welling, A., Ludwig, A., Zimmer, S., Klugbauer, N., Flockerzi,
V. and Hofmann, F. (1997) Circ. Res. 81, 526^532.
[14] Schneider, T., Wei, X., Olcese, R., Costantin, J.L., Neely, A.,
Palade, P., Perez-Reyes, E., Qin, N., Zhou, J., Crawford, G.D.,
Smith, R.G., Appel, S.H., Stefani, E. and Birnbaumer, L. (1994)
Receptors Channels 2, 255^270.
[15] Biel, M., Ruth, P., Bosse, E., Hullin, R., Stu«hmer, W., Flockerzi,
V. and Hofmann, F. (1990) FEBS Lett. 269, 409^412.
[16] Kalasz, H., Watanabe, T., Yabana, H., Itagaki, K., Naito, K.,
Nakayama, H., Schwartz, A. and Vaghy, P.L. (1993) FEBS Lett.
331, 177^181.
FEBS 22033 18-5-99
L. Lacinova¤ et al./FEBS Letters 451 (1999) 152^156156
